Spinal Muscular Atrophy (SMA) Treatment Market Insights: Opportunities, Trends, Demand, Growth Outlook [2025-2030]


Spinal Muscular Atrophy (SMA) Treatment Market Insights: Opportunities, Trends, Demand, Growth Outlook [2025-2030]

.

How Big is the Spinal Muscular Atrophy (SMA) Treatment Market?

The Global Spinal Muscular Atrophy (SMA) Treatment Market size was valued at around USD 2.3 billion in 2023 and is projected to reach around USD 30.2 billion by 2030. Along with this, the market is anticipated to grow at a CAGR of around 18.2% during the forecast period, i.e., 2025-30. It is projected that the progress in the Global Spinal Muscular Atrophy (SMA) Treatment Market will be propelled mainly by innovations in gene therapy in addition to the higher focus on research and development of rare genetic disorders. The growing awareness of SMA due to early identification is escalating the demand for SMA treatment.

Market Statistics

  • Market Size in 2023: USD 2.3 billion
  • Market Size By 2030: USD 30.2 billion
  • Market Growth Rate (CAGR): 18.2% from 2025-2030

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  https://www.marknteladvisors.com/query/request-sample/spinal-muscular-atrophy-sma-treatment-market.html

Spinal Muscular Atrophy (SMA) Treatment Market Insight:

Driver-

Growing Incidence of the Disorder to Augment the Market – In terms of cost and healthcare services, the overall burden of spinal muscular atrophy is one of the highest in the rare disorder. With multiple incidences of spinal muscular atrophy popping up due to the increase in population, the requirement for SMA treatment is growing drastically on a global level. As per the Spinal Muscular Atrophy Foundation estimations, 1 in every 6000 to 10000 babies are diagnosed with this, despite being considered a rare disorder. Thus the rising rampancy of this disorder is one of the major factors that increases revenue generation from the market. Moreover, the rising awareness regarding novel therapies and the increasing number of product launches are some of the major factors deriving market growth. The high need for quality treatment options coupled with the awareness about the lethal backlash of the disorder will significantly aid in the development of the market.

 Spinal Muscular Atrophy (SMA) Treatment Market Segmentation:

The report has segmented the market into the following categories:

By Type

  • Type I- Market Size Forecast 2020-2030, USD Million
  • Type II- Market Size Forecast 2020-2030, USD Million
  • Type III- Market Size Forecast 2020-2030, USD Million
  • Type IV- Market Size Forecast 2020-2030, USD Million

By Treatment

  • Gene Therapy- Market Size Forecast 2020-2030, USD Million
  • Disease-Modifying Drugs- Market Size Forecast 2020-2030, USD Million

By Drug Type

  • Nusinersen- Market Size Forecast 2020-2030, USD Million
  • Onasemnogene Abeparvovec- Market Size Forecast 2020-2030, USD Million
  • Others- Market Size Forecast 2020-2030, USD Million

By Route of Administration

  • Oral- Market Size Forecast 2020-2030, USD Million
  • Injectable- Market Size Forecast 2020-2030, USD Million

By Distribution Channel

  • Hospital Pharmacies- Market Size Forecast 2020-2030, USD Million
  • Retail Pharmacies- Market Size Forecast 2020-2030, USD Million
  • Online Pharmacies- Market Size Forecast 2020-2030, USD Million

By End User

  • Hospitals- Market Size Forecast 2020-2030, USD Million
  • Homecare- Market Size Forecast 2020-2030, USD Million
  • Specialty Clinics- Market Size Forecast 2020-2030, USD Million
  • Others- Market Size Forecast 2020-2030, USD Million

By Region

  • North America
  • South America
  • Europe
  • The Middle East Africa
  • Asia-Pacific

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/spinal-muscular-atrophy-sma-treatment-market.html

Competitive Landscape:

  • Biogen
  • Novartis AG
  • Hoffmann-La Roche Ltd
  • Cytokinetics
  • PTC Therapeutics, Inc.
  • Ionis Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • NMD Pharma A/S
  • Genzyme Corporation
  • Genentech, Inc.
  • Pfizer Inc.
  • Scholar Rock Holding Corporation
  • Novo Nordisk A/S
  • Takeda Pharmaceutical Co. Ltd.

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Key Highlights of the Report:

  • Market Performance (2025-2030)
  • Strategic Recommendations
  • Current, Historical and Future Market Trends
  • Market Drivers and Leading Competitor
  • SWOT Analysis
  • Structure of the Market
  • Comprehensive Mapping and Recent Advancement

Other Report:

About Us –

We are a leading market research company, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Comments